PNC Financial Services Group’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.7K | Sell |
555
-60
| -10% | -$2.02K | ﹤0.01% | 3603 |
|
|
2025
Q1 | $19.6K | Hold |
615
| – | – | ﹤0.01% | 3550 |
|
|
2024
Q4 | $23.9K | Sell |
615
-926
| -60% | -$36K | ﹤0.01% | 3445 |
|
|
2024
Q3 | $69.4K | Sell |
1,541
-14
| -0.9% | -$630 | ﹤0.01% | 2892 |
|
|
2024
Q2 | $64.9K | Hold |
1,555
| – | – | ﹤0.01% | 2894 |
|
|
2024
Q1 | $70.8K | Hold |
1,555
| – | – | ﹤0.01% | 2805 |
|
|
2023
Q4 | $71.9K | Hold |
1,555
| – | – | ﹤0.01% | 2787 |
|
|
2023
Q3 | $63.3K | Sell |
1,555
-63
| -4% | -$2.56K | ﹤0.01% | 2826 |
|
|
2023
Q2 | $78.4K | Hold |
1,618
| – | – | ﹤0.01% | 2788 |
|
|
2023
Q1 | $79.7K | Sell |
1,618
-81
| -5% | -$3.99K | ﹤0.01% | 2707 |
|
|
2022
Q4 | $86K | Sell |
1,699
-113
| -6% | -$5.72K | ﹤0.01% | 2667 |
|
|
2022
Q3 | $91K | Sell |
1,812
-196,332
| -99% | -$9.86M | ﹤0.01% | 2597 |
|
|
2022
Q2 | $9.68M | Sell |
198,144
-7,799
| -4% | -$381K | 0.01% | 494 |
|
|
2022
Q1 | $12.4M | Sell |
205,943
-23,491
| -10% | -$1.41M | 0.01% | 475 |
|
|
2021
Q4 | $18.2M | Sell |
229,434
-15,888
| -6% | -$1.26M | 0.02% | 428 |
|
|
2021
Q3 | $21.7M | Buy |
245,322
+14,555
| +6% | +$1.29M | 0.02% | 375 |
|
|
2021
Q2 | $23M | Buy |
230,767
+35,666
| +18% | +$3.55M | 0.02% | 373 |
|
|
2021
Q1 | $17.5M | Buy |
195,101
+19,220
| +11% | +$1.73M | 0.02% | 401 |
|
|
2020
Q4 | $16.6M | Buy |
175,881
+19,226
| +12% | +$1.82M | 0.02% | 394 |
|
|
2020
Q3 | $11.3M | Buy |
156,655
+22,319
| +17% | +$1.61M | 0.01% | 433 |
|
|
2020
Q2 | $9.44M | Buy |
+134,336
| New | +$9.44M | 0.01% | 456 |
|